VLKIM
RNA

Van Lanschot Kempen Investment Management’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,996,253
Closed -$37.4M – 138
2014
Q4 		$37.4M Hold
1,996,253
– – 4.12% 1
2014
Q3 		$16.8M Hold
1,996,253
– – 1.75% 25
2014
Q2 		$25.2M Hold
1,996,253
– – 2.44% 23
2014
Q1 		$11.2M Hold
1,996,253
– – 1.07% 28
2013
Q4 		$9.32M Buy
+1,996,253
New +$9.1M 0.78% 31

Van Lanschot Kempen Investment Management's RNA Position: Q1 2015 in Review

Van Lanschot Kempen Investment Management sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 1,996,253 shares — an estimated $37.4M sold.

Van Lanschot Kempen Investment Management first reported a position in RNA in Q4 2013 and held it in 5 quarters. The position peaked at $37.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • Van Lanschot Kempen Investment Management reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 1,996,253 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $37.4M.
  • Van Lanschot Kempen Investment Management first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2013 and held it in 5 quarters.
  • Van Lanschot Kempen Investment Management's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $37.4M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2015, filed 15 May 2015.